The FDA has approved Medtronic's Affera cardiac mapping and ablation system and Sphere-9 catheter. Other companies, including Kardium, have also received FDA approvals for similar pulsed field ablation systems. The approvals appear to be part of a larger trend of growth and development in heart technology, with multiple companies announcing milestones and advancements in their cardiac treatment products.